Ledger.Open graph →
SEC Form D · filed November 20, 2019

Cardurion Pharmaceuticals, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jeb Keiper · Boston, MADirectorAmy Schulman · Boston, MADirectorKenneth Novack · Boston, MADirectorMichael Mendelsohn · Boston, MAExec · DirectorDain N. Zaitz · Wilsonville, ORDirectorRobert D. Milks, Jr · Grayson, GADirectorJustin M. Scott · Mt. Pleasant, SCExec · DirectorChristopher N. Crow · Wilsonville, ORDirectorConstantine H. Iordanou · Hamilton, BermudaDirectorBrian H. Schreiber · Washington, Washington, D.C.DirectorDalton M. Dale · ST. PETERSBURG, FLDirectorDesmond E. Mitchell · Luxembourg, LuxembourgExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗